Catalyst Wire Dossier Catalyst Wire Dossier

Acarmet

metformin HCl 500 mg + acarbose 50 mg · Lotus Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acarmet, covering 2010-11-22 to 2010-11-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus [Phase 3]

See pricing